Showing results (51-60 of 151) with videos related to
Sort By:
Pageof 16
American Journal of Physiology. Renal Physiology|April 12, 2013
The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubulesHarshini Mudaliar, Carol Pollock, Muralikrishna Gangadharan Komala, et al.Bone Reports|March 14, 2022
Bisphosphonates and bone mineral density in patients with end-stage kidney disease and renal transplants: A 15-year single-centre experienceDominic Hauck, Liza Nery, Rachel O'Connell, et al.International Journal of Clinical and Experimental Pathology|February 20, 2014
Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathyJin Ma, Huiling Wu, Cathy Y Zhao, et al.Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|July 24, 2003
Albumin and glucose effects on cell growth parameters, albumin uptake and Na(+)/H(+)-exchanger Isoform 3 in OK cellsKarina Drumm, Erwin Lee, Scott Stanners, et al.Scientific Reports|June 28, 2020
RIPK3 blockade attenuates tubulointerstitial fibrosis in a mouse model of diabetic nephropathyYing Shi, Chunling Huang, Yongli Zhao, et al.Plos One|January 12, 2022
Correction: A Cationic-Independent Mannose 6-Phosphate Receptor Inhibitor (PXS64) Ameliorates Kidney Fibrosis by Inhibiting Activation of Transforming Growth Factor-β1Jie Zhang, Muh Geot Wong, May Wong, et al.Clinical Kidney Journal|April 4, 2022
How common is hyperkalaemia? A systematic review and meta-analysis of the prevalence and incidence of hyperkalaemia reported in observational studiesToby Humphrey, Mogamat Razeen Davids, Mogamat-Yazied Chothia, et al.Plos One|February 7, 2015
A cationic-independent mannose 6-phosphate receptor inhibitor (PXS64) ameliorates kidney fibrosis by inhibiting activation of transforming growth factor-β1Jie Zhang, Muh Geot Wong, May Wong, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 17, 2020
RIPK3 blockade attenuates kidney fibrosis in a folic acid model of renal injuryYing Shi, Chunling Huang, Hao Yi, et al.Clinical Kidney Journal|February 2, 2023
Alleviating symptoms in patients undergoing long-term hemodialysis: a focus on chronic kidney disease-associated pruritusRajiv Agarwal, James Burton, Maurizio Gallieni, et al.Pageof 16